2009—2011年我院麻醉药品应用分析  

Utilization of Narcotic Analgesics in Our Hospital During 2009-2011

作　　者：石春生[1] 

机构地区：[1]首都医科大学密云教学医院麻醉科,北京101500

出　　处：《中国医院用药评价与分析》2012年第7期594-596,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解我院麻醉药品应用情况及变化趋势,为临床合理用药提供参考。方法:对我院2009—2011年麻醉药品的销售金额、用药频度(DDDs)、限定日费用(DDC)等进行统计、分析。结果:3年中,我院麻醉药品的销售金额、DDDs均逐年增加,其中吗啡口服制剂、注射用瑞芬太尼和舒芬太尼用量呈明显上升趋势,主要用于手术麻醉前、中、后的镇静与镇痛。结论:在《癌症三阶梯止痛治疗原则》指导下,我院麻醉药品用药结构渐趋合理,临床医师对麻醉药品的使用基本合理。OBJECTIVE： To investigate the status quo and variation tendency of the utilization of narcotic analgesics in our hospital so as to provide reference for clinical rational use of this kind of drugs.METHODS： The narcotic analgesics used in our hospital from 2009 to 2011 were analyzed statistically in respect of consumption sum,DDDs and DDC etc.RESULTS： Over the 3 years,both the consumption sum and DDDs of narcotic analgesics increased year by year.The consumption amount of oral Morphine,Remifentanil Hydrochloride for Injection and Sufentanil Citrate for injection increased significantly,which were used primarily for conscious-sedation and analgesia before,during or after anesthesia.CONCLUSION： Directed by the three-step analgesic ladder approach for cancer pain,the application structure of narcotic drugs in our hospital has gradually become reasonable and the use of narcotic drugs was rational on the whole.

关 键 词：麻醉药品 用药频度 限定日费用 用药分析 

分 类 号：R971.2[医药卫生—药品]